- News and Insights
- About Us
Introduction to Drug Valuation is a tactical course invaluable for organizations that work in both preclinical/early clinical development all the way to mature biopharma. Develop knowledge of the core elements of drug valuation including pricing, competitive assessments, and epidemiology. Understand how the geography of the US, EU, Japan, China, and the rest of the world impacts drug valuation. Join our industry experts as they bring to life the ‘logical process’ of drug valuation using real-life case studies that participants work through together.
The scope of this course includes:
Appropriate for those who need a foundational understanding of drug valuation and how it pertains to drug pricing. Ideal for anyone who works in finance, marketing, business development, project management and research development.
CLS Members save even more with early bird registration – register before March 15 to secure these savings!
CLS members | Early bird: $1395; Regular: $1595
Non-member | Early bird: $1495; Regular: $1695